## Abstract Epigenetic changes have been implicated in the pathogenesis of solid tumors, including head and neck squamous cell carcinoma (HNSCC). Prior efforts have primarily examined regional promoter hypermethylation as a silencer of tumor suppressor gene expression. To analyze the global state o
Association of IgA-anti-Fab autoantibodies with disease stage in head-and-neck cancer
✍ Scribed by C. Süsal; H. Maier; K. Lorenz; G. Opelz
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- French
- Weight
- 425 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Patients with head-and-neck cancer commonly have immune defects. It was reported that these patients have raised serum IgA levels. We investigated whether IgA-anti-Fab autoantibodies, which occur in association with immune dysfunction, are present in patients with head-and-neck cancer. Sera of 101 patients with squamous-cell carcinoma (SCCHN) and 8 patients with adenoid cystic carcinoma (ACCHN) of the head and neck were tested in ELISA for IgA-anti-Fab autoantibody activity.
IgA-anti-Fab serum activity was significantly higher in both SCCHN and ACCHN patients than in healthy controls. In patients with SCCHN, an association between disease stage and IgA-anti-Fab activity was established. Stage-IV patients had significantly higher IgA-anti-Fab than stage-I patients or healthy controls. Stage4 and stage-Ill patients had intermediate levels.
Extremely high IgA-anti-Fab activity was observed in 7 patients who died within 6 months following testing, suggesting a relationship of autoimmunity with terminal disintegration of physiological body functions. IgA-anti-Fab autoantibodies may explain the occurrence of immune defects in patients with head-and-neck cancer.
📜 SIMILAR VOLUMES
## Abstract ## __Background.__ To determine if depression portends a worse prognosis in patients with head and neck cancer, we conducted a retrospective chart analysis of subjects who participated in a randomized placebo‐controlled trial of citalopram for the prevention of depression during head a
## Abstract ## BACKGROUND: The purpose of the study was to identify predictors of weight loss during radiotherapy (RT) in patients with stage I or II head and neck (HN) cancer. ## METHODS: This study was conducted as part of a phase 3 chemoprevention trial. A total of 540 patients were randomize
## Abstract ## Background Identifying patients with head and neck cancer at greatest risk of poor health‐related quality of life (HRQOL) will facilitate screening for such patients and targeted interventions. ## Methods This was a cross‐sectional, self‐administered survey with medical record rev
## Abstract Squamous cell carcinoma of the head and neck (SCCHN), which is relatively prevalent in Korea, is believed to be induced by environmental carcinogens and host genetic factors. Accumulating evidence has shown that genetic differences in DNA repair capacity resulting from genetic polymorph
Background. The relationship between type of chemoradiation treatment, site of disease, and swallowing function has not been sufficiently examined in patients with head and neck cancer treated primarily with chemoradiation. Methods. Fifty-three patients with advanced-stage head and neck cancer were